| Health / Medical Topics |
Tigatuzumab
A humanized agonistic monoclonal antibody directed against human tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) with potential antitumor activity. Mimicking the natural receptor ligand TRAIL, tigatuzumab binds to TRAIL-R2, activating signal transduction pathways that may result in tumor cell apoptosis and a reduction in tumor growth. A member of the tumor necrosis factor (TNF) receptor family, TRAIL-R2, also known as DR5 (death receptor 5), is expressed on the surfaces of many types of malignant cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A synthetic 15-mer peptide corresponding to amino acids 31-45 of the 94-amino acid isoform of human prostate secretory protein (PSP-94) with potential…
A bitmap graphics file format utilizing tagged fields.
A thiadiazine derivative with hypoglycemic activity. Like sulfonylureas, tifenazoxide binds to ATP-sensitive inwardly-rectifier potassium Kir6.2/SUR1 (IKATP) channels on the membrane of pancreatic…
Human TIE1 wild-type allele is located within 1p34-p33 and is approximately 22 kb in length. This allele, which encodes tyrosine-protein kinase receptor…
This gene plays a regulatory role in angiogenesis.
Line, ribbon, or cord used for fastening, or drawing the container closed.
